Wave Life Sciences Ltd. WVE 深 沪
等待开盘 01-30 09:30:00 美东时间
13.01
+0.280
+2.20%
华盛通- 最 高13.1389
- 今 开12.65
- 成交量 356.50万股
- 最 低 12.61
- 昨 收 12.73
- 总市值 20.69亿
- 52周最高 21.73
- 市盈率 静 --
- 换手率 2.24%
- 52周最低 5.28
- 委 比 22.94%
- 总股本 1.59亿
- 历史最高 56.00
- 量 比 0.74
- 振 幅 4.15%
- 历史最低 1.16
- 每 手 1
- 风险率 3.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wave Life Sciences sets 2026 strategy, highlights obesity program
Wave Life Sciences ( ($WVE) ) has issued an update. On January 12, 2026, Wave L...
01-12 20:59
Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
<p>Wave Life Sciences Ltd. (Nasdaq: WVE), a biotechnology company specializing in RNA medicines, announced that its CEO, Paul Bolno, MD, MBA, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026, at 2:15 p.m. PT / 5:15 p.m. ET. A live webcast and replay of the presentation will be available on the company's website. Wave focuses on developing RNA-based therapies for treating rare and common diseas...
01-05 13:30
美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
2025-12-22 15:05
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
Truist Securities Maintains Buy on WAVE Life Sciences, Raises Price Target to $50
Truist Securities analyst Joon Lee maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $36 to $50.
2025-12-15 22:36
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
2025-12-15 15:30
美股周涨跌榜 | “减肥神药”临床数据引爆！WaVe生命科学周涨121%；太空概念股Planet Labs周涨42.8%
“减肥神药”临床数据引爆！WaVe生命科学周涨121%；福尼克斯周内飙升50%，创历史新高；SpaceX上市传闻引爆市场，太空概念股Planet Labs周涨42.8%>>
2025-12-13 10:07
Wave Life Science prices upsized $350M stock ofeering
Wave Life Sciences (WVE) priced an upsized underwritten public offering of ~15.8M shares at a price to the public of $19.00 per ordinary share and pre-funded warrants to purchase up to 2.63M at $18.99...
2025-12-10 14:53
